申请人:WARNER-LAMBERT COMPANY
公开号:EP0181109A2
公开(公告)日:1986-05-14
There is disclosed a compound of the following general formula (I)
its diastereomers of mixtures thereof, or a pharmaceutically acceptable acid addition salt thereof; wherein R1 is a radical of the formula
or
in which Y is 0, S, SO, or SO2; X and X' are each, independently, hydrogen, lower alkyl, lower alkoxy, hydroxy, lower alkanoyl, nitro, amino, trifluoromethyl, halogen, or, when taken together, the radical -O-CH2-O-; A and B are each, independently, hydrogen or lower alkyl; and A' and B' are each, independently, hydrogen, lower alkyl or hydroxyl;
R2 is (a) hydrogen, (b) halogen (c)-NRiRii in which Ri and R" are independently hydrogen, lower alkyl, phenyl or phenyl substituted by lower alkyl, lower alkoxy, halogen or trifluoromethyl, (d)-SR in which R is hydrogen, lower alkyl, or phenyl; and
R2', R3', and R5' are each, independently, hydrogen, lower alkanoyl, benzoyl, or benzoyl substituted by lower alkyl, lower alkoxy, halogen, or trifluoromethyl, or R2, and R3', when taken together, may be lower alkylidene;
The compounds have having highly desirable central nervous system antiinflammatory and antihypertensive properties.
本发明公开了一种通式(I)如下的化合物
其非对映异构体及其混合物,或其药学上可接受的酸加成盐;其中 R1 是式中的基团
或
其中,Y 是 0、S、SO 或 SO2;X 和 X'各自独立地是氢、低级烷基、低级烷氧基、羟基、低级烷酰基、硝基、氨基、三氟甲基、卤素,或当合在一起时,是自由基 -O-CH2-O-;A 和 B 各自独立地是氢或低级烷基;A'和 B'各自独立地是氢、低级烷基或羟基;
R2 是 (a) 氢,(b) 卤素 (c)-NRiRii 其中 Ri 和 R "各自独立地是氢、低级烷基、苯基或被低级烷基、低级烷氧基、卤素或三氟甲基取代的苯基, (d)-SR 其中 R 是氢、低级烷基或苯基;以及
R2'、R3'和 R5'各自独立地为氢、低级烷酰基、苯甲酰基或被低级烷基、低级烷氧基、卤素或三氟甲基取代的苯甲酰基,或 R2 和 R3'合在一起可为低级亚烷基;
这些化合物具有非常理想的中枢神经系统抗炎和抗高血压特性。